The DOI matches its OpenAlex record.
Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking
Abstract
BACKGROUND: Many previous studies of the influence of sociodemographic and clinical factors on the development of renal failure in patients with lupus nephritis have been based on selected subgroups of patients and have yielded conflicting results. We sought to determine the prognostic importance of patient demographic characteristics (age, gender, race, and socioeconomic status), smoking status, and hypertension in the development of end-stage renal disease (ESRD) among patients with lupus nephritis. METHODS: This retrospective cohort study followed an inception cohort of 160 adults with lupus nephritis. The outcome measure was the development of ESRD, defined as the institution of maintenance dialysis or measurement of a creatinine clearance of 10 mL/min or less. Life-table analysis was used to determine differences between patient subgroups in the time to development of ESRD. RESULTS: End-stage renal disease developed in 41 (26%) of 160 patients followed up for a median of 6.4 years. Hypertension and smoking status at the onset of nephritis were strongly associated with differences in the time to development of ESRD. The median time to ESRD among patients with moderate to severe hypertension (diastolic blood pressure, greater than or equal to 105 mm Hg) was 7 months, among patients with mild hypertension (diastolic blood pressure, 90 to 104 mm Hg) it was 146 months, and among normotensive patients it was greater than 273 months. The median time to ESRD among smokers was 145 months and among nonsmokers it was greater than 273 months. These effects persisted in multivariable analyses adjusting for differences among patients in age, gender, socioeconomic status, renal histology, and immunosuppressive treatment. The independent effects of hypertension and smoking resulted in shorter times to renal failure among patients who were both hypertensive and smoking, compared with nonsmoking hypertensive patients. The development of ESRD did not differ among patient demographic subgroups. CONCLUSION: Patient demographic characteristics had no detectable impact on the rate of progression to ESRD in this cohort. Hypertension and smoking appear to be important, potentially modifiable, factors influencing the prognosis of patients with lupus nephritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Effects of tobacco smoke on immunity, inflammation and autoimmunity
Arnson, Y., Shoenfeld, Y., & Amital, H. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.12.003 · Cited by 967
The frequency and outcome of lupus nephritis: results from an international inception cohort study
Hanly, J. G., O’Keeffe, A. G., Su, L., Urowitz, M. B., Romero-Diaz, J., Gordon, C., Bae, S.-C., Bernatsky, S., Clarke, A. E., Wallace, D. J., et al. (2016) · Rheumatology · doi:10.1093/rheumatology/kev311 · Cited by 647
Tektonidou, M. G., Dasgupta, A., & Ward, M. M. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39594 · Cited by 582
Self-citationHaroun, M. K., Jaar, B. G., Hoffman, S. C., Comstock, G. W., Klag, M. J., & Coresh, J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000095249.99803.85 · Cited by 532
The global burden of SLE: prevalence, health disparities and socioeconomic impact
Carter, E. E., Barr, S. G., & Clarke, A. E. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.137 · Cited by 497
Epidemiology of systemic lupus erythematosus
Petri, M. (2002) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2002.0259 · Cited by 401
Bastian, H. M., Roseman, J. M., Mcgwin, G., Alarcón, G. S., Friedman, A. W., Fessler, B. J., Baethge, B. A., Reveille, J. D., & Lumina Study Group (2002) · Lupus · doi:10.1191/0961203302lu158oa · Cited by 360
Smoking as a risk factor for end-stage renal failure in men with primary renal disease
Orth, S. R., Stöckmann, A., Conradt, C., Ritz, E., Ferro, M., Kreusser, W., Piccoli, G., Rambausek, M., Roccatello, D., Schäfer, K., et al. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00067.x · Cited by 314
Pons‐Estel, G. J., Alarcón, G. S., McGwin, G., Danila, M. I., Zhang, J., Bastian, H. M., Reveille, J. D., & Vilá, L. M. (2009) · Arthritis Care & Research · doi:10.1002/art.24538 · Cited by 306
Orth, S. R., & Hallan, S. I. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03740907 · Cited by 290
Predicting initiation and progression of chronic kidney disease: Developing renal risk scores
Taal, M. W., & Brenner, B. M. (2006) · Kidney International · doi:10.1038/sj.ki.5001794 · Cited by 282
“Nephritic flares” are predictors of bad long-term renal outcome in lupus nephritis
Moroni, G., Quaglini, S., Maccario, M., Banfi, G., & Ponticelli, C. (1996) · Kidney International · doi:10.1038/ki.1996.528 · Cited by 267
Mortality and causes of death in systemic lupus erythematosus
Trager, J., & Ward, M. M. (2001) · Current Opinion in Rheumatology · doi:10.1097/00002281-200109000-00002 · Cited by 264
Self-citationLiang, M. H., Schur, P. H., Fortin, P., St.Clair, E. W., Balow, J. E., Costenbader, K., Crofford, L., Pablo, P. D., Dooley, M. A., Finckh, A., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21625 · Cited by 263
Helping patients with ESRD and earlier stages of CKD to quit smoking
Formanek, P., Salisbury-Afshar, E., & Afshar, M. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.01.057 · Cited by 31
Metadata
- Authors
- Ward, M. M.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association
- Published
- 1992-10-01
- Volume
- 152
- Issue
- 10
- Pages
- 2082-2088
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W4243491909
- Cited by
- 184
- References
- 0
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.